Daniela Elgueta
Overview
Explore the profile of Daniela Elgueta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cornejo F, Franchini N, Cortes B, Elgueta D, Cancino G
Front Cell Dev Biol
. 2024 Mar;
12:1357862.
PMID: 38487272
Neurodevelopmental disorders are characterized by alterations in the development of the cerebral cortex, including aberrant changes in the number and function of neural cells. Although neurogenesis is one of the...
2.
Marin T, Valls C, Jerez C, Huerta T, Elgueta D, Vidal R, et al.
IBRO Neurosci Rep
. 2023 Jan;
13:378-387.
PMID: 36590096
Parkinson's disease is the second most common neurodegenerative disorder. Although it is clear that dopaminergic neurons degenerate, the underlying molecular mechanisms are still unknown, and thus, successful treatment is still...
3.
Elgueta D, Chovar O, Ugalde V, Sanchez-Guajardo V, Catenaccio A, Court F, et al.
J Vis Exp
. 2022 Aug;
(185).
PMID: 35969046
Parkinson's disease is a neurodegenerative disorder that involves the death of the dopaminergic neurons of the nigrostriatal pathway and, consequently, the progressive loss of control of voluntary movements. This neurodegenerative...
4.
Elgueta D, Murgas P, Riquelme E, Yang G, Cancino G
Front Immunol
. 2022 Apr;
13:816619.
PMID: 35464419
Infections during pregnancy can seriously damage fetal neurodevelopment by aberrantly activating the maternal immune system, directly impacting fetal neural cells. Increasing evidence suggests that these adverse impacts involve alterations in...
5.
Montoya A, Elgueta D, Campos J, Chovar O, Falcon P, Matus S, et al.
J Neuroinflammation
. 2019 Dec;
16(1):258.
PMID: 31810491
Background: Neuroinflammation constitutes a pathogenic process leading to neurodegeneration in several disorders, including Alzheimer's disease, Parkinson's disease (PD) and sepsis. Despite microglial cells being the central players in neuroinflammation, astrocytes...
6.
Elgueta D, Contreras F, Prado C, Montoya A, Ugalde V, Chovar O, et al.
Front Immunol
. 2019 May;
10:981.
PMID: 31118938
Neuroinflammation constitutes a fundamental process involved in Parkinson's disease (PD). Microglial cells play a central role in the outcome of neuroinflammation and consequent neurodegeneration of dopaminergic neurons in the substantia...
7.
Campos-Acuna J, Elgueta D, Pacheco R
Front Immunol
. 2019 Mar;
10:239.
PMID: 30828335
Parkinson's disease (PD) is a neurodegenerative disorder affecting mainly the dopaminergic neurons of the nigrostriatal pathway, a neuronal circuit involved in the control of movements, thereby the main manifestations correspond...
8.
Elgueta D, Aymerich M, Contreras F, Montoya A, Celorrio M, Rojo-Bustamante E, et al.
Neuropharmacology
. 2016 Nov;
113(Pt A):110-123.
PMID: 27693549
Neuroinflammation involves the activation of glial cells, which is associated to the progression of neurodegeneration in Parkinson's disease. Recently, we and other researchers demonstrated that dopamine receptor D3 (D3R)-deficient mice...
9.
Contreras F, Prado C, Gonzalez H, Franz D, Osorio-Barrios F, Osorio F, et al.
J Immunol
. 2016 May;
196(10):4143-9.
PMID: 27183640
Dopamine receptor D3 (DRD3) expressed on CD4(+) T cells is required to promote neuroinflammation in a murine model of Parkinson's disease. However, how DRD3 signaling affects T cell-mediated immunity remains...
10.
Franz D, Contreras F, Gonzalez H, Prado C, Elgueta D, Figueroa C, et al.
J Neuroimmunol
. 2015 May;
284:18-29.
PMID: 26025054
Dopamine receptors have been described in T-cells, however their signalling pathways coupled remain unknown. Since cAMP and ERKs play key roles regulating T-cell physiology, we aim to determine whether cAMP...